Previous studies have primarily focused on various pathological components of AD, such as Aβ peptide deposits, tau hyperphosphorylation, neuroinflammation, neuronal injury, and neurotransmitter homeostasis [44–47]. The gene discussed is MAPT; the disease is Alzheimer disease.